BARD C R INC (BCR) [Rocket]

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Vascular	1,014.9	970.3	928.3	830.0	845.0	842.4	755.9	681.5
Oncology	1,012.1	936.9	910.9	857.1	812.4	779.5	724.8	678.7
Urology	951.8	845.0	835.9	776.6	757.8	734.8	718.1	700.3
Surgical Specialties	637.3	572.3	555.1	499.0	455.1	450.0	434.6	387.8
Other	97.9	91.5	93.4	86.8	87.8	89.7	86.8	86.6
Total revenues	3,714.0	3,416.0	3,323.6	3,049.5	2,958.1	2,896.4	2,720.2	2,534.9
Revenue growth [+]	8.7%	2.8%	9.0%	3.1%	2.1%	6.5%	7.3%	3.4%
Vascular	4.6%	4.5%	11.8%	-1.8%	0.3%	11.4%	10.9%	6.0%
Oncology	8.0%	2.9%	6.3%	5.5%	4.2%	7.5%	6.8%	5.0%
Urology	12.6%	1.1%	7.6%	2.5%	3.1%	2.3%	2.5%	-1.2%
Surgical Specialties	11.4%	3.1%	11.2%	9.6%	1.1%	3.5%	12.1%	5.3%
Other	-53.3%	-3.5%	150.0%	-76.2%	307.4%	3.3%	0.2%	1.1%
Cost of goods sold	1,371.7	1,301.2	1,258.6	1,194.4	1,125.3	1,097.3	1,020.0	959.0
Gross profit	2,342.3	2,114.8	2,065.0	1,855.1	1,832.8	1,799.1	1,700.2	1,575.9
Gross margin	63.1%	61.9%	62.1%	60.8%	62.0%	62.1%	62.5%	62.2%
Selling, general and administrative	1,101.9	1,012.1	981.5	920.3	817.3	794.6	759.8	682.5
Research and development	292.8	259.2	302.0	295.7	203.2	185.4	185.4	179.6
Other operating expenses						-230.9
EBITDA [+]	1,161.0	1,036.6	955.6	785.5	948.6	1,165.1	859.9	807.3
EBITDA growth	12.0%	8.5%	21.7%	-17.2%	-18.6%	35.5%	6.5%	17.8%
EBITDA margin	31.3%	30.3%	28.8%	25.8%	32.1%	40.2%	31.6%	31.8%
Depreciation	82.9	73.6	65.3	56.9	53.6	51.8	51.8	51.0
EBITA	1,078.1	963.0	890.3	728.6	895.0	1,113.3	808.1	756.3
EBITA margin	29.0%	28.2%	26.8%	23.9%	30.3%	38.4%	29.7%	29.8%
Amortization of intangibles	130.5	119.5	108.8	89.5	82.7	63.3	53.1	42.5
EBIT [+]	947.6	843.5	781.5	639.1	812.3	1,050.0	755.0	713.8
EBIT growth	12.3%	7.9%	22.3%	-21.3%	-22.6%	39.1%	5.8%	20.1%
EBIT margin	25.5%	24.7%	23.5%	21.0%	27.5%	36.3%	27.8%	28.2%
Non-recurring items						230.9
Interest expense, net [+]	52.9	44.0	42.8	43.7	34.1	32.9	9.0	8.2
Interest expense	54.5	44.9	44.8	45.0	39.6	36.4	12.7	11.8
Interest income	1.6	0.9	2.0	1.3	5.5	3.5	3.7	3.6
Other income (expense), net	-231.0	-450.1	-292.9	618.0	-45.8	-275.4	-28.3	-34.1
Pre-tax income	663.7	349.4	445.8	1,213.4	732.4	510.8	717.7	671.5
Income taxes	132.3	214.0	151.3	523.6	202.3	182.8	208.1	210.1
Tax rate	19.9%	61.2%	33.9%	43.2%	27.6%	35.8%	29.0%	31.3%
Minority interest							0.4	1.3
Net income	531.4	135.4	294.5	689.8	530.1	328.0	509.2	460.1
Net margin	14.3%	4.0%	8.9%	22.6%	17.9%	11.3%	18.7%	18.2%

Basic EPS [+]	$7.18	$1.83	$3.90	$8.70	$6.36	$3.82	$5.45	$4.71
Growth	293.0%	-53.1%	-55.2%	36.7%	66.5%	-29.9%	15.8%	12.5%
Diluted EPS [+]	$7.07	$1.80	$3.82	$8.55	$6.28	$3.76	$5.38	$4.65
Growth	293.5%	-53.0%	-55.3%	36.1%	67.2%	-30.2%	15.8%	13.3%

Dividends per share [+]	$1.02	$0.94	$0.87	$0.83	$0.79	$0.75	$0.71	$0.67
Growth	8.5%	8.0%	4.8%	5.1%	5.3%	5.6%	6.0%	6.3%

Shares outstanding (basic) [+]	74.0	74.1	75.6	79.3	83.3	85.8	93.4	97.7
Growth	-0.1%	-2.0%	-4.7%	-4.8%	-2.9%	-8.1%	-4.4%	-1.8%
Shares outstanding (diluted) [+]	75.2	75.4	77.1	80.7	84.4	87.3	94.6	99.0
Growth	-0.3%	-2.2%	-4.5%	-4.4%	-3.3%	-7.7%	-4.4%	-2.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.